Delivery Order SPE2DB22D2206-SPE2DB24FJK97

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The firm-fixed-price contract has a ceiling value of $12,629.20 and an ultimate completion date of August 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts to provide a wide range of...
This is a $16,837.90 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REVATIO 20 MG TABLET 90S. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription drugs to support military treatment facilities and other government healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $25,632.77 firm fixed-price delivery order contract for REVATIO 20 MG TABLET 90S, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of REVATIO 20 MG tablets. The contract has a firm fixed price of $8,846.49 and an ultimate completion date of September 13, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,866.34, is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,331.48 firm fixed price delivery order is for the supply of REVATIO 20 MG tablets. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $18,035.96 and an ultimate completion date of September 5, 2024. The order is a firm-fixed price contract, indicating a pre-determined price for the goods. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $21,376.93 and is a firm fixed-price contract. There is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supports various government agencies and healthcare programs through its extensive federal contract awards. This delivery order is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for $47,426.86. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2024 and is a firm fixed-price contract. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4565754299 - REVATIO 20 MG TABLET 90S. The contract has a firm fixed price of $6,577.14 and a completion date of September 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the comprehensive...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJK97
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $19,836.35 firm fixed-price contract is for the delivery of REVATIO 20 MG tablets. The ultimate completion date is July 26, 2024. This order is not associated with a set-aside program. AmerisourceBergen has been awarded multiple IDCs by various government agencies, including the DLA Troop Support Medical (up to $999,999,999 through December 2025) and the Department of Justice Federal Bureau of Investigation (up to $750,000 through May 2024), to provide a wide range of pharmaceutical and medical products to support federal healthcare programs and facilities.

Generated 10/27/24, 4:12 AM